Dr. Maoxin Wu, M.D., PH.D.
What this data tells you about Dr. Wu
Dr. Maoxin Wu is a pathology - anatomic specialist in Stony Brook, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Wu performed 3,117 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wu received a total of $104 from 1 pharmaceutical and/or device company across 1 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary — 2023
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
1,315 | $19 | $80 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
583 | $32 | $120 |
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
365 | $24 | $60 |
| Fine needle aspirate evaluation and report A pathologist examines cells collected via a fine needle aspiration and provides a written interpretation and report of the findings. |
278 | $58 | $180 |
| Intraoperative pathology examination of specimen A pathology test performed during surgery to examine a tissue sample from the initial site. The results help guide the surgeon's immediate decisions. |
153 | $53 | $160 |
| Fine needle aspirate evaluation A laboratory examination of cells collected via fine needle aspiration to assess for abnormalities. |
100 | $30 | $90 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
94 | $30 | $130 |
| Additional Pap test evaluation episode An additional immediate evaluation of a fine needle aspirate sample during a Pap test procedure. |
80 | $23 | $70 |
| Intraoperative pathology exam, additional site A microscopic examination of tissue samples performed during surgery to check for disease. This code applies to each additional site examined beyond the first. |
75 | $31 | $135 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
30 | $125 | $1,800 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
26 | $23 | $80 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
18 | $11 | $35 |
Industry Payment Transparency
Open Payments through 2018 ↗Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2018)
Associated products mentioned in payments ›
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2018 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wu is a mixed practice specialist, with above-average Medicare volume (top 17% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wu experienced with cell examination of specimen, concentration technique?
Does Dr. Wu receive payments from pharmaceutical companies?
How do Dr. Wu's costs compare to other pathology - anatomics in Stony Brook?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology